← Back to Search

Oral Tranexamic Acid for Postoperative Hemorrhage

Phase 4
Waitlist Available
Research Sponsored by University of Liege
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Primary arthroscopic surgery for anterior cruciate ligament reconstruction
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first 24 hours after surgery
Awards & highlights
All Individual Drugs Already Approved
Pivotal Trial
Drug Has Already Been Approved

Summary

To find superiority relationship between oral and intravenous administration of tranexamic acid on peroperative and postoperative blood loss, haemarthrosis prevalence and improvement functional prognosis in anterior cruciate ligament arthroscopy.

Eligible Conditions
  • Hemorrhage
  • Postoperative Hemorrhage
  • Anterior Cruciate Ligament Rupture
  • Arthroscopy

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first 24 hours after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and first 24 hours after surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assessment of haemarthrosis
Secondary study objectives
Clinical evaluation of functional recovery
Length of hospital stay
Postoperative pain

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Oral Tranexamic AcidActive Control1 Intervention
52 patients scheduled for primary anteriori cruciate ligament surgery by arthroscopy
Group II: PlaceboPlacebo Group1 Intervention
52 patients scheduled for primary anteriori cruciate ligament surgery by arthroscopy

Find a Location

Who is running the clinical trial?

University of LiegeLead Sponsor
265 Previous Clinical Trials
70,382 Total Patients Enrolled
1 Trials studying Postoperative Hemorrhage
230 Patients Enrolled for Postoperative Hemorrhage
~24 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top